Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Measuring Kidney Perfusion, pH, and Renal Clearance Consecutively Using MRI and Multispectral Optoacoustic Tomography.

Minhas AS, Sharkey J, Randtke EA, Murray P, Wilm B, Pagel MD, Poptani H.

Mol Imaging Biol. 2019 Sep 16. doi: 10.1007/s11307-019-01429-z. [Epub ahead of print]

PMID:
31529408
2.

Imaging of cancer lipid metabolism in response to therapy.

Arlauckas SP, Browning EA, Poptani H, Delikatny EJ.

NMR Biomed. 2019 May 20:e4070. doi: 10.1002/nbm.4070. [Epub ahead of print]

PMID:
31107583
3.

Methodological consensus on clinical proton MRS of the brain: Review and recommendations.

Wilson M, Andronesi O, Barker PB, Bartha R, Bizzi A, Bolan PJ, Brindle KM, Choi IY, Cudalbu C, Dydak U, Emir UE, Gonzalez RG, Gruber S, Gruetter R, Gupta RK, Heerschap A, Henning A, Hetherington HP, Huppi PS, Hurd RE, Kantarci K, Kauppinen RA, Klomp DWJ, Kreis R, Kruiskamp MJ, Leach MO, Lin AP, Luijten PR, Marjańska M, Maudsley AA, Meyerhoff DJ, Mountford CE, Mullins PG, Murdoch JB, Nelson SJ, Noeske R, Öz G, Pan JW, Peet AC, Poptani H, Posse S, Ratai EM, Salibi N, Scheenen TWJ, Smith ICP, Soher BJ, Tkáč I, Vigneron DB, Howe FA.

Magn Reson Med. 2019 Aug;82(2):527-550. doi: 10.1002/mrm.27742. Epub 2019 Mar 28. Review.

PMID:
30919510
4.

Detection of occult neoplastic infiltration in the corpus callosum and prediction of overall survival in patients with glioblastoma using diffusion tensor imaging.

Mohan S, Wang S, Coban G, Kural F, Chawla S, O'Rourke DM, Poptani H.

Eur J Radiol. 2019 Mar;112:106-111. doi: 10.1016/j.ejrad.2019.01.015. Epub 2019 Jan 15.

PMID:
30777198
5.

Three-dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma.

Verma G, Chawla S, Mohan S, Wang S, Nasrallah M, Sheriff S, Desai A, Brem S, O'Rourke DM, Wolf RL, Maudsley AA, Poptani H.

NMR Biomed. 2019 Feb;32(2):e4042. doi: 10.1002/nbm.4042. Epub 2018 Dec 17.

6.

Non-invasive imaging reveals conditions that impact distribution and persistence of cells after in vivo administration.

Scarfe L, Taylor A, Sharkey J, Harwood R, Barrow M, Comenge J, Beeken L, Astley C, Santeramo I, Hutchinson C, Ressel L, Smythe J, Austin E, Levy R, Rosseinsky MJ, Adams DJ, Poptani H, Park BK, Murray P, Wilm B.

Stem Cell Res Ther. 2018 Nov 28;9(1):332. doi: 10.1186/s13287-018-1076-x.

7.

Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma.

Wang S, O'Rourke DM, Chawla S, Verma G, Nasrallah MP, Morrissette JJD, Plesa G, June CH, Brem S, Maloney E, Desai A, Wolf RL, Poptani H, Mohan S.

Br J Cancer. 2019 Jan;120(1):54-56. doi: 10.1038/s41416-018-0342-0. Epub 2018 Nov 27.

PMID:
30478409
8.

Magnetic Resonance Imaging for Characterization of a Chick Embryo Model of Cancer Cell Metastases.

Herrmann A, Taylor A, Murray P, Poptani H, Sée V.

Mol Imaging. 2018 Jan-Dec;17:1536012118809585. doi: 10.1177/1536012118809585.

9.

Noninvasive imaging of nanoparticle-labeled transplant populations within polymer matrices for neural cell therapy.

Tickle JA, Poptani H, Taylor A, Chari DM.

Nanomedicine (Lond). 2018 Jun;13(11):1333-1348. doi: 10.2217/nnm-2017-0347.

10.

Linking spatial gene expression patterns to sex-specific brain structural changes on a mouse model of 16p11.2 hemideletion.

Kumar VJ, Grissom NM, McKee SE, Schoch H, Bowman N, Havekes R, Kumar M, Pickup S, Poptani H, Reyes TM, Hawrylycz M, Abel T, Nickl-Jockschat T.

Transl Psychiatry. 2018 May 29;8(1):109. doi: 10.1038/s41398-018-0157-z.

11.

Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI.

Chawla S, Wang S, Mohan S, Nasrallah M, Verma G, Brem S, O'Rourke DM, Wolf RL, Poptani H, Nabavizadeh SA.

J Magn Reson Imaging. 2019 Jan;49(1):184-194. doi: 10.1002/jmri.26053. Epub 2018 Apr 20.

PMID:
29676844
12.

A convolutional neural network to filter artifacts in spectroscopic MRI.

Gurbani SS, Schreibmann E, Maudsley AA, Cordova JS, Soher BJ, Poptani H, Verma G, Barker PB, Shim H, Cooper LAD.

Magn Reson Med. 2018 Nov;80(5):1765-1775. doi: 10.1002/mrm.27166. Epub 2018 Mar 9.

PMID:
29520831
13.

Measurement of blood-brain barrier permeability using dynamic contrast-enhanced magnetic resonance imaging with reduced scan time.

Bae J, Zhang J, Wadghiri YZ, Minhas AS, Poptani H, Ge Y, Kim SG.

Magn Reson Med. 2018 Oct;80(4):1686-1696. doi: 10.1002/mrm.27145. Epub 2018 Mar 5.

PMID:
29508443
14.

Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies.

Scarfe L, Brillant N, Kumar JD, Ali N, Alrumayh A, Amali M, Barbellion S, Jones V, Niemeijer M, Potdevin S, Roussignol G, Vaganov A, Barbaric I, Barrow M, Burton NC, Connell J, Dazzi F, Edsbagge J, French NS, Holder J, Hutchinson C, Jones DR, Kalber T, Lovatt C, Lythgoe MF, Patel S, Patrick PS, Piner J, Reinhardt J, Ricci E, Sidaway J, Stacey GN, Starkey Lewis PJ, Sullivan G, Taylor A, Wilm B, Poptani H, Murray P, Goldring CEP, Park BK.

NPJ Regen Med. 2017 Oct 19;2:28. doi: 10.1038/s41536-017-0029-9. eCollection 2017. Review.

15.

Dynamic Contrast-Enhanced MRI-Derived Intracellular Water Lifetime (τ i ): A Prognostic Marker for Patients with Head and Neck Squamous Cell Carcinomas.

Chawla S, Loevner LA, Kim SG, Hwang WT, Wang S, Verma G, Mohan S, LiVolsi V, Quon H, Poptani H.

AJNR Am J Neuroradiol. 2018 Jan;39(1):138-144. doi: 10.3174/ajnr.A5440. Epub 2017 Nov 16.

16.

Dynamic and accurate assessment of acetaminophen-induced hepatotoxicity by integrated photoacoustic imaging and mechanistic biomarkers in vivo.

Brillant N, Elmasry M, Burton NC, Rodriguez JM, Sharkey JW, Fenwick S, Poptani H, Kitteringham NR, Goldring CE, Kipar A, Park BK, Antoine DJ.

Toxicol Appl Pharmacol. 2017 Oct 1;332:64-74. doi: 10.1016/j.taap.2017.07.019. Epub 2017 Jul 26.

17.

Magnetic Resonance Spectroscopy for Detection of 2-Hydroxyglutarate as a Biomarker for IDH Mutation in Gliomas.

Leather T, Jenkinson MD, Das K, Poptani H.

Metabolites. 2017 Jun 19;7(2). pii: E29. doi: 10.3390/metabo7020029. Review.

18.

Non-uniformly weighted sampling for faster localized two-dimensional correlated spectroscopy of the brain in vivo.

Verma G, Chawla S, Nagarajan R, Iqbal Z, Albert Thomas M, Poptani H.

J Magn Reson. 2017 Apr;277:104-112. doi: 10.1016/j.jmr.2017.02.012. Epub 2017 Feb 22.

PMID:
28262561
19.

Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors.

Arlauckas SP, Kumar M, Popov AV, Poptani H, Delikatny EJ.

Oncotarget. 2017 Mar 7;8(10):16518-16530. doi: 10.18632/oncotarget.14965.

20.

Co-precipitation of DEAE-dextran coated SPIONs: how synthesis conditions affect particle properties, stem cell labelling and MR contrast.

Barrow M, Taylor A, García Carrión J, Mandal P, Park BK, Poptani H, Murray P, Rosseinsky MJ, Adams DJ.

Contrast Media Mol Imaging. 2016 Sep;11(5):362-370. doi: 10.1002/cmmi.1700. Epub 2016 Jun 30.

PMID:
27358113
21.

Non-invasive detection of 2-hydroxyglutarate in IDH-mutated gliomas using two-dimensional localized correlation spectroscopy (2D L-COSY) at 7 Tesla.

Verma G, Mohan S, Nasrallah MP, Brem S, Lee JY, Chawla S, Wang S, Nagarajan R, Thomas MA, Poptani H.

J Transl Med. 2016 Sep 22;14(1):274.

22.

Creatine CEST MRI for Differentiating Gliomas with Different Degrees of Aggressiveness.

Cai K, Tain RW, Zhou XJ, Damen FC, Scotti AM, Hariharan H, Poptani H, Reddy R.

Mol Imaging Biol. 2017 Apr;19(2):225-232. doi: 10.1007/s11307-016-0995-0.

23.

Imaging technologies for monitoring the safety, efficacy and mechanisms of action of cell-based regenerative medicine therapies in models of kidney disease.

Sharkey J, Scarfe L, Santeramo I, Garcia-Finana M, Park BK, Poptani H, Wilm B, Taylor A, Murray P.

Eur J Pharmacol. 2016 Nov 5;790:74-82. doi: 10.1016/j.ejphar.2016.06.056. Epub 2016 Jul 1. Review.

24.

Assessment of early response to tumor-treating fields in newly diagnosed glioblastoma using physiologic and metabolic MRI: initial experience.

Mohan S, Chawla S, Wang S, Verma G, Skolnik A, Brem S, Peters KB, Poptani H.

CNS Oncol. 2016 Jul;5(3):137-44. doi: 10.2217/cns-2016-0003. Epub 2016 Apr 14.

25.

Evaluating the effectiveness of transferrin receptor-1 (TfR1) as a magnetic resonance reporter gene.

Pereira SM, Herrmann A, Moss D, Poptani H, Williams SR, Murray P, Taylor A.

Contrast Media Mol Imaging. 2016 May;11(3):236-44. doi: 10.1002/cmmi.1686. Epub 2016 Feb 29.

26.

Development of Multifunctional Magnetic Nanoparticles for Genetic Engineering and Tracking of Neural Stem Cells.

Adams C, Israel LL, Ostrovsky S, Taylor A, Poptani H, Lellouche JP, Chari D.

Adv Healthc Mater. 2016 Apr 6;5(7):841-9. doi: 10.1002/adhm.201500885. Epub 2016 Feb 11.

PMID:
26867130
27.

Diffusion Tensor Imaging for Assessing Brain Gray and White Matter Abnormalities in a Feline Model of α-Mannosidosis.

Kumar M, Duda JT, Yoon SY, Bagel J, O'Donnell P, Vite C, Pickup S, Gee JC, Wolfe JH, Poptani H.

J Neuropathol Exp Neurol. 2016 Jan;75(1):35-43. Erratum in: J Neuropathol Exp Neurol. 2017 Feb 1;76(2):158.

28.

Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.

Wang S, Martinez-Lage M, Sakai Y, Chawla S, Kim SG, Alonso-Basanta M, Lustig RA, Brem S, Mohan S, Wolf RL, Desai A, Poptani H.

AJNR Am J Neuroradiol. 2016 Jan;37(1):28-36. doi: 10.3174/ajnr.A4474. Epub 2015 Oct 8.

29.

Prognostic Value of Dynamic Susceptibility Contrast-Enhanced and Diffusion-Weighted MR Imaging in Patients with Glioblastomas.

Çoban G, Mohan S, Kural F, Wang S, O'Rourke DM, Poptani H.

AJNR Am J Neuroradiol. 2015 Jul;36(7):1247-52. doi: 10.3174/ajnr.A4284. Epub 2015 Apr 2.

30.

Magnetic resonance spectroscopy for detection of choline kinase inhibition in the treatment of brain tumors.

Kumar M, Arlauckas SP, Saksena S, Verma G, Ittyerah R, Pickup S, Popov AV, Delikatny EJ, Poptani H.

Mol Cancer Ther. 2015 Apr;14(4):899-908. doi: 10.1158/1535-7163.MCT-14-0775. Epub 2015 Feb 5.

31.

High resolution magnetic resonance imaging for characterization of the neuroligin-3 knock-in mouse model associated with autism spectrum disorder.

Kumar M, Duda JT, Hwang WT, Kenworthy C, Ittyerah R, Pickup S, Brodkin ES, Gee JC, Abel T, Poptani H.

PLoS One. 2014 Oct 9;9(10):e109872. doi: 10.1371/journal.pone.0109872. eCollection 2014.

32.

CEST signal at 2ppm (CEST@2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor.

Cai K, Singh A, Poptani H, Li W, Yang S, Lu Y, Hariharan H, Zhou XJ, Reddy R.

NMR Biomed. 2015 Jan;28(1):1-8. doi: 10.1002/nbm.3216. Epub 2014 Oct 8.

33.

Tongue fat and its relationship to obstructive sleep apnea.

Kim AM, Keenan BT, Jackson N, Chan EL, Staley B, Poptani H, Torigian DA, Pack AI, Schwab RJ.

Sleep. 2014 Oct 1;37(10):1639-48. doi: 10.5665/sleep.4072.

34.

In vivo magnetic resonance imaging of tumor protease activity.

Haris M, Singh A, Mohammed I, Ittyerah R, Nath K, Nanga RP, Debrosse C, Kogan F, Cai K, Poptani H, Reddy D, Hariharan H, Reddy R.

Sci Rep. 2014 Aug 15;4:6081. doi: 10.1038/srep06081.

35.

Extraventricular neurocytoma and ganglioneurocytoma: advanced MR imaging, histopathological, and chromosomal findings.

Nabavizadeh SA, Chawla S, Baccon J, Zhang PJ, Poptani H, Melhem ER, Vossough A.

J Neuroimaging. 2014 Nov-Dec;24(6):613-616. doi: 10.1111/jon.12081. Epub 2014 Feb 19.

PMID:
24787229
36.

Clinical proton MR spectroscopy in central nervous system disorders.

Oz G, Alger JR, Barker PB, Bartha R, Bizzi A, Boesch C, Bolan PJ, Brindle KM, Cudalbu C, Dinçer A, Dydak U, Emir UE, Frahm J, González RG, Gruber S, Gruetter R, Gupta RK, Heerschap A, Henning A, Hetherington HP, Howe FA, Hüppi PS, Hurd RE, Kantarci K, Klomp DW, Kreis R, Kruiskamp MJ, Leach MO, Lin AP, Luijten PR, Marjańska M, Maudsley AA, Meyerhoff DJ, Mountford CE, Nelson SJ, Pamir MN, Pan JW, Peet AC, Poptani H, Posse S, Pouwels PJ, Ratai EM, Ross BD, Scheenen TW, Schuster C, Smith IC, Soher BJ, Tkáč I, Vigneron DB, Kauppinen RA; MRS Consensus Group.

Radiology. 2014 Mar;270(3):658-79. doi: 10.1148/radiol.13130531. Review.

37.

Diagnostic utility of diffusion tensor imaging in differentiating glioblastomas from brain metastases.

Wang S, Kim SJ, Poptani H, Woo JH, Mohan S, Jin R, Voluck MR, O'Rourke DM, Wolf RL, Melhem ER, Kim S.

AJNR Am J Neuroradiol. 2014 May;35(5):928-34. doi: 10.3174/ajnr.A3871. Epub 2014 Feb 6.

38.

Quantitative, noninvasive, in vivo longitudinal monitoring of gene expression in the brain by co-AAV transduction with a PET reporter gene.

Yoon SY, Gay-Antaki C, Ponde DE, Poptani H, Vite CH, Wolfe JH.

Mol Ther Methods Clin Dev. 2014 Jun 4;1:14016. doi: 10.1038/mtm.2014.16. eCollection 2014.

39.

High-resolution magnetic resonance microscopy and diffusion tensor imaging to assess brain structural abnormalities in the murine mucopolysaccharidosis VII model.

Kumar M, Nasrallah IM, Kim S, Ittyerah R, Pickup S, Li J, Parente MK, Wolfe JH, Poptani H.

J Neuropathol Exp Neurol. 2014 Jan;73(1):39-49. doi: 10.1097/NEN.0000000000000023.

40.

Radiation injury to the normal brain measured by 3D-echo-planar spectroscopic imaging and diffusion tensor imaging: initial experience.

Chawla S, Wang S, Kim S, Sheriff S, Lee P, Rengan R, Lin A, Melhem E, Maudsley A, Poptani H.

J Neuroimaging. 2015 Jan-Feb;25(1):97-104. doi: 10.1111/jon.12070. Epub 2013 Nov 26.

PMID:
24279509
41.

Implementation of two-dimensional L-COSY at 7 Tesla: an investigation of reproducibility in human brain.

Verma G, Hariharan H, Nagarajan R, Nanga RP, Delikatny EJ, Albert Thomas M, Poptani H.

J Magn Reson Imaging. 2014 Dec;40(6):1319-27. doi: 10.1002/jmri.24510. Epub 2013 Nov 22.

42.

Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor grade.

Sahin N, Melhem ER, Wang S, Krejza J, Poptani H, Chawla S, Verma G.

Neuroradiol J. 2013 Oct;26(5):531-41. Epub 2013 Nov 7.

43.

Magnetic Resonance Spectroscopy for Differentiating Pseudo-Progression from True Progression in GBM on Concurrent Chemoradiotherapy.

Sawlani V, Taylor R, Rowley K, Redfern R, Martin J, Poptani H.

Neuroradiol J. 2012 Nov;25(5):575-86. Epub 2012 Nov 9.

PMID:
24029093
44.

Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma.

Arias-Mendoza F, Payne GS, Zakian K, Stubbs M, O'Connor OA, Mojahed H, Smith MR, Schwarz AJ, Shukla-Dave A, Howe F, Poptani H, Lee SC, Pettengel R, Schuster SJ, Cunningham D, Heerschap A, Glickson JD, Griffiths JR, Koutcher JA, Leach MO, Brown TR.

Acad Radiol. 2013 Sep;20(9):1122-9. doi: 10.1016/j.acra.2013.04.013.

45.

A Bayesian diagnostic system to differentiate glioblastomas from solitary brain metastases.

Chen R, Wang S, Poptani H, Melhem ER, Herskovits EH.

Neuroradiol J. 2013 Apr;26(2):175-83. Epub 2013 May 10.

46.

MR spectroscopy of head and neck cancer.

Abdel Razek AA, Poptani H.

Eur J Radiol. 2013 Jun;82(6):982-9. doi: 10.1016/j.ejrad.2013.01.025. Epub 2013 Feb 26. Review.

PMID:
23485098
47.

Morphologic MRI features, diffusion tensor imaging and radiation dosimetric analysis to differentiate pseudo-progression from early tumor progression.

Agarwal A, Kumar S, Narang J, Schultz L, Mikkelsen T, Wang S, Siddiqui S, Poptani H, Jain R.

J Neurooncol. 2013 May;112(3):413-20. doi: 10.1007/s11060-013-1070-1. Epub 2013 Feb 18.

PMID:
23417357
48.

Differentiation between oligodendroglioma genotypes using dynamic susceptibility contrast perfusion-weighted imaging and proton MR spectroscopy.

Chawla S, Krejza J, Vossough A, Zhang Y, Kapoor GS, Wang S, O'Rourke DM, Melhem ER, Poptani H.

AJNR Am J Neuroradiol. 2013 Aug;34(8):1542-9. doi: 10.3174/ajnr.A3384. Epub 2013 Jan 31.

49.

Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging.

Verma G, Woo JH, Chawla S, Wang S, Sheriff S, Elman LB, McCluskey LF, Grossman M, Melhem ER, Maudsley AA, Poptani H.

Radiology. 2013 Jun;267(3):851-7. doi: 10.1148/radiol.13121148. Epub 2013 Jan 29.

50.

Mechanisms of blood flow and hypoxia production in rat 9L-epigastric tumors.

Koch CJ, Jenkins WT, Jenkins KW, Yang XY, Shuman AL, Pickup S, Riehl CR, Paudyal R, Poptani H, Evans SM.

Tumor Microenviron Ther. 2013 Jan;1:1-13.

Supplemental Content

Loading ...
Support Center